(1S,3S,4R,7S,8R,10S)-4-hydroxy-3,8-dimethyl-13-methylidene-5,11-dioxatricyclo[8.3.0.03,7]tridecane-6,12-dione

Details

Top
Internal ID edd6c623-d7f3-4d31-9c51-bfa5251de42d
Taxonomy Organoheterocyclic compounds > Lactones > Gamma butyrolactones
IUPAC Name (1S,3S,4R,7S,8R,10S)-4-hydroxy-3,8-dimethyl-13-methylidene-5,11-dioxatricyclo[8.3.0.03,7]tridecane-6,12-dione
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C14H18O5/c1-6-4-9-8(7(2)11(15)18-9)5-14(3)10(6)12(16)19-13(14)17/h6,8-10,13,17H,2,4-5H2,1,3H3/t6-,8+,9+,10-,13-,14+/m1/s1
InChI Key RTAJEBNCRIONGW-YZLNCIPLSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C14H18O5
Molecular Weight 266.29 g/mol
Exact Mass 266.11542367 g/mol
Topological Polar Surface Area (TPSA) 72.80 Ų
XlogP 1.70
Atomic LogP (AlogP) 1.01
H-Bond Acceptor 5
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1S,3S,4R,7S,8R,10S)-4-hydroxy-3,8-dimethyl-13-methylidene-5,11-dioxatricyclo[8.3.0.03,7]tridecane-6,12-dione

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9810 98.10%
Caco-2 + 0.5053 50.53%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability - 0.5143 51.43%
Subcellular localzation Mitochondria 0.7114 71.14%
OATP2B1 inhibitior - 0.8553 85.53%
OATP1B1 inhibitior + 0.8838 88.38%
OATP1B3 inhibitior + 0.8809 88.09%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.9635 96.35%
P-glycoprotein inhibitior - 0.8918 89.18%
P-glycoprotein substrate - 0.8072 80.72%
CYP3A4 substrate + 0.6018 60.18%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8748 87.48%
CYP3A4 inhibition - 0.7458 74.58%
CYP2C9 inhibition - 0.8697 86.97%
CYP2C19 inhibition - 0.9061 90.61%
CYP2D6 inhibition - 0.9620 96.20%
CYP1A2 inhibition - 0.7385 73.85%
CYP2C8 inhibition - 0.8403 84.03%
CYP inhibitory promiscuity - 0.9728 97.28%
UGT catelyzed + 0.5362 53.62%
Carcinogenicity (binary) - 0.9143 91.43%
Carcinogenicity (trinary) Non-required 0.5032 50.32%
Eye corrosion - 0.9706 97.06%
Eye irritation - 0.8520 85.20%
Skin irritation - 0.5876 58.76%
Skin corrosion - 0.8812 88.12%
Ames mutagenesis + 0.6430 64.30%
Human Ether-a-go-go-Related Gene inhibition - 0.7544 75.44%
Micronuclear - 0.6400 64.00%
Hepatotoxicity + 0.8064 80.64%
skin sensitisation - 0.6916 69.16%
Respiratory toxicity + 0.7667 76.67%
Reproductive toxicity + 0.6667 66.67%
Mitochondrial toxicity + 0.7875 78.75%
Nephrotoxicity + 0.7703 77.03%
Acute Oral Toxicity (c) II 0.5134 51.34%
Estrogen receptor binding + 0.7545 75.45%
Androgen receptor binding + 0.6085 60.85%
Thyroid receptor binding - 0.5990 59.90%
Glucocorticoid receptor binding - 0.5428 54.28%
Aromatase binding - 0.6646 66.46%
PPAR gamma - 0.6129 61.29%
Honey bee toxicity - 0.7481 74.81%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity + 0.5600 56.00%
Fish aquatic toxicity + 0.9880 98.80%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 93.86% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.87% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.64% 95.56%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.43% 97.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 86.17% 99.23%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 82.60% 96.09%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 82.59% 85.14%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.97% 100.00%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Psilostrophe villosa

Cross-Links

Top
PubChem 162978224
LOTUS LTS0000876
wikiData Q105245003